Clinical Policy Title: Laser thermal ablation for epileptic seizures
|
|
- Lambert Reynolds
- 5 years ago
- Views:
Transcription
1 Clinical Policy Title: Laser thermal ablation for epileptic seizures Clinical Policy Number: Effective Date: October 1, 2014 Initial Review Date: June 5, 2014 Most Recent Review Date: June 22, 2017 Next Review Date: June 2018 Related policies: Policy contains: Drug-resistant epilepsy. Laser-induced interstitial thermotherapy (LITT). Laser thermal ablation. Magnetic resonance imaging (MRI)- guided laser thermal ablation. Visualase thermal therapy system. CP# Vagus nerve stimulation ABOUT THIS POLICY: Keystone First has developed clinical policies to assist with making coverage determinations. Keystone First s clinical policies are based on guidelines from established industry sources, such as the Centers for Medicare & Medicaid Services (CMS), state regulatory agencies, the American Medical Association (AMA), medical specialty professional societies, and peer-reviewed professional literature. These clinical policies along with other sources, such as plan benefits and state and federal laws and regulatory requirements, including any state- or plan-specific definition of medically necessary, and the specific facts of the particular situation are considered by Keystone First when making coverage determinations. In the event of conflict between this clinical policy and plan benefits and/or state or federal laws and/or regulatory requirements, the plan benefits and/or state and federal laws and/or regulatory requirements shall control. Keystone First s clinical policies are for informational purposes only and not intended as medical advice or to direct treatment. Physicians and other health care providers are solely responsible for the treatment decisions for their patients. Keystone First s clinical policies are reflective of evidence-based medicine at the time of review. As medical science evolves, Keystone First will update its clinical policies as necessary. Keystone First s clinical policies are not guarantees of payment. Coverage policy Keystone First considers the use of laser thermal ablation for epileptic seizures to be investigational/experimental and, therefore, not medically necessary. Limitations: All other uses of laser thermal ablation for epileptic seizures are considered to be investigational/experimental and, therefore, not medically necessary. Alternative covered services: Open surgical resection. Background 1
2 A seizure is a temporary disturbance in brain function caused by excessive or abnormal signals in groups of neurons in the brain. Seizures may produce changes in awareness or sensation, involuntary movements, or other changes in behavior. Usually, a seizure lasts from a few seconds to a few minutes. Epilepsy, sometimes referred to as seizure disorder, is a general term that refers to a tendency to have recurrent seizures (CDC, 2014). The CDC estimates 2.3 million adults and 467,711 children (0 17 years of age) in the United States have epilepsy; nearly 150,000 Americans develop the condition each year. New cases of epilepsy are most common among children and older adults (CDC, 2014). Causes of epilepsy may be related to hereditary factors, early exposures, and events. In up to two-thirds of epilepsy cases, a specific underlying cause is not identified. Known conditions and events that may lead to epilepsy include (Epilepsy Foundation, 2014): Oxygen deprivation (e.g., during childbirth). Brain infections (e.g., meningitis, encephalitis, cysticercosis, or brain abscess). Traumatic brain injury or head injury. Stroke (resulting from a block or rupture of a blood vessel in the brain). Other neurologic diseases (e.g., Alzheimer s disease). Brain tumors. Certain genetic disorders. Women with epilepsy can experience difficulties arising from hormonal changes during their reproductive cycle that sometimes affect the tendency to have seizures. Pregnancy brings some special considerations for women with epilepsy, because seizure occurrence and certain drugs taken during this time may sometimes carry a risk of harm to the developing fetus (Epilepsy Foundation, 2014). Epileptic seizures are categorized broadly as generalized or partial seizures. Primary generalized seizures are seizures that begin with widespread involvement of both sides of the brain, whereas partial seizures begin with involvement of a smaller, localized area of the brain. With some partial seizures, the disturbance can still spread within seconds or minutes to involve widespread areas of the brain causing a secondary generalized seizure (Epilepsy Foundation, 2014). Drug Treatment and drug-resistant epilepsy: Antiepileptic drug (AED) therapy is the treatment of choice for persons with epilepsy. For approximately two-thirds of people with a correct diagnosis of epilepsy receiving optimum treatment, AEDs are successful in fully controlling seizures. For the remainder, seizures remain uncontrolled with AEDs. According to the Epilepsy Foundation, while the definition of uncontrolled (also referred to as refractory, medically intractable, and pharmacoresistant ) epilepsy varies, there is general agreement the definition should take into account the frequency and severity of seizure activity that is troublesome enough to seriously interfere with quality of life (Epilepsy Foundation, 2014). The International League Against Epilepsy (ILAE) has proposed the following definition of drug-resistant 2
3 epilepsy, and suggests using this term instead of the term refractory epilepsy if both of the following conditions are met (ILAE, 2014): Drug-resistant epilepsy occurs when a person has failed to become (and stay) seizure-free with adequate trials of two AEDs. These seizure medications must have been chosen appropriately for the person s seizure type, tolerated by the person, and tried alone or together with other seizure medications. Surgical treatment: For persons with drug-resistant epilepsy, other treatment options are available for seizure control (Engel, 2014). These include epilepsy surgery, vagus nerve stimulation, and dietary therapies. The goal of surgery is to remove the smallest amount of tissue in order to achieve a seizure-free outcome. Multiple types of surgical interventions are now offered depending on the cause and type of epileptic seizures. Most patients experience a reduction in, or elimination of, disabling seizures and significant improvement in quality of life (CDC, 2014; Engel, 2014). Surgical therapy is among the most cost-effective treatment options in appropriately chosen patients, in part because pre-surgical evaluation can be performed noninvasively in most cases. Pre-surgical evaluation requires localizing and determining the extent of the epileptogenic region, which is defined as the area of brain necessary and sufficient to generate habitual seizures. A number of different functional and structural tests are used to approximate extent of the epileptic region, including inpatient video- electroencephalogram (EEG) monitoring, neuroimaging, and neuropsychological evaluation (Engel, 2014). In addition to drug resistance, optimal surgical candidates have partial seizure conditions with a known pathophysiology and progressive features, such as developmental delay in infants and young children, or interictal behavioral disorders, most commonly depression (Engel, 2014). Mesial temporal lobe epilepsy (MTLE) is the most common form of epilepsy in adolescents and adults, the most medically refractory, and the most easily treated surgically (Engel, 2014). In most patients with MTLE, a discrete seizure focus originates within hippocampal sclerosis lesions. Other surgically remediable conditions include focal epilepsies within discrete resectable structural lesions; epilepsies due to diffuse hemispheric disturbances, such as hemimegalencephaly, Rasmussen's encephalitis, Sturge-Weber syndrome and large porencephalic cysts; and gelastic seizures with hypothalamic hamartomas (Engel, 2014). Laser thermal ablation for epilepsy: Laser thermal ablation is a minimally invasive, stereotactic surgical technique that combines an imageguided system using magnetic resonance imaging (MRI) with thermal ablation to localize high temperatures generated by the local absorption of laser energy to destroy the desired tissue. Surgeons make a 1-cm incision in the skull through which an intracranial probe is inserted and guided to the target by MRI; thermal ablation can be visualized in real time (Tovar-Spinoza, 2013). 3
4 This procedure is also called laser-induced interstitial thermotherapy (LITT), laser interstitial thermal therapy, laser-induced thermotherapy, interstitial laser therapy and laser ablation. As a minimally invasive technique, theoretically critical adjacent tissue can be spared and open resection can be performed in the event ablation is ineffective. Laser thermal ablation may be an alternative to surgical resection for the treatment of focal lesional epilepsy in patients who are considered high-risk surgical candidates. The U.S. Food and Drug Administration approved the Visualase thermal ablation system in 2010, and the NeuroBlate MRI-guided laser ablation system in Both assist in identifying the target tissue and hold the patient s head in place while the laser is situated for precise ablation (MD Edge, 2015). Searches Keystone First searched PubMed and the databases of: UK National Health Services Centre for Reviews and Dissemination. Agency for Healthcare Research and Quality Guideline Clearinghouse and evidence-based practice centers. The Centers for Medicare & Medicaid Services (CMS). We conducted searches on April 21, Search terms were: "magnetic resonance imaging (MeSH), "epilepsy/surgery (MeSH), and "laser therapy" (MeSH), and free text terms laser interstitial thermal therapy, laser thermal ablation, visualase, and epilepsy. We included: Systematic reviews, which pool results from multiple studies to achieve larger sample sizes and greater precision of effect estimation than in smaller primary studies. Systematic reviews use predetermined transparent methods to minimize bias, effectively treating the review as a scientific endeavor, and are thus rated highest in evidence-grading hierarchies. Guidelines based on systematic reviews. Economic analyses, such as cost-effectiveness, and benefit or utility studies (but not simple cost studies), reporting both costs and outcomes sometimes referred to as efficiency studies which also rank near the top of evidence hierarchies. Findings As of April 2017, there were no professional guidelines that address laser thermal ablation for epileptic seizures. A recent review of 22 articles (n=223) included mostly those having undergone treatment with Visualase for epilepsy (eight studies). No significant differences were found compared with NeuroBlate therapy for frame, total complications, and length of stay (Lagman, 2017). Another recent review discussed publications of about 200 cases of epilepsy treated with laser thermal ablation; it found 4
5 seizure outcome to be slightly worse than respective surgery, and recommended future studies covering patient outcomes and cost-benefit analyses (Hoppe, 2017). One Hayes report of MRI-guided laser ablation addresses treatment of epilepsy (Hayes, 2017), as does one additional case series (Curry, 2012) that used the Visualase Thermal Therapy System (Visualase Inc., Houston, TX, now marketed by Medtronic Inc., Minneapolis, MN). The Hayes report included 12 abstracts from the literature, and found a low quality of evidence due to small sample sizes and several reports authored by manufacturers of the product. Despite some promising outcomes, future studies will need to select patients judiciously, and ensure adequate surgeon experience with the new procedure to optimize safety and efficacy (Hayes, 2017). A group of 38 patients with medically refractory mesial temporal lobe epilepsy were followed from six to 38.5 months. Researchers found lower procedure time, hospitalization time, and analgesic requirement when compared with open surgery, suggesting that this new therapy may lower seizure rates. Longerterm and larger studies are required (Waseem, 2017). The proportion of a group of 20 patients with epilepsy who underwent laser interstitial thermal therapy who had no seizures included: 53 percent (eight of 15) after six months 36 percent (four of 11) after one year 60 percent (three of five) after two years Another review of 17 pediatric patients with epilepsy (mean age at surgery = 15.3 years) documented an average length of stay after surgery of 1.56 days. Follow-up (mean 16.1 months) showed seven of 17 patients classified as Engel class I (optimal), followed by one, three, and six in classes II, III, and IV (Lewis, 2015). Other recent reviews conclude that laser interstitial thermal therapy for drug-resistant epilepsy has potential to replace more invasive surgical techniques (Kang, 2017; Wicks, 2017). Pediatric patients with epilepsy may also be candidates for this new therapy (Karsy, 2016; Muh, 2016). Policy updates: A total of one guideline/other and eight peer-reviewed references were added to this policy. Summary of clinical evidence: Citation Hayes (2017) Content, Methods, Recommendations Key points: Clinical evidence for Visualase for epilepsy Literature search found 12 abstracts of safety and efficacy of Visualase MRI-guided laser ablation therapy for epileptic patients. Overall quality of studies were low due to small samples and several reports with authors who are manufacturers. Some results show promise with this new therapy, but authors cautioned that patients should be selected judiciously, and surgeons need to be experienced. 5
6 Citation Lagman (2017) Content, Methods, Recommendations Advantages of Visualase include reduced time of procedure, little/no hair removed, minimal sutures required, shorter stays, less scarring than surgery. Key points: Systematic analysis of MRIguided laser interstitial thermal therapies Review of 22 articles (n=223) having undergone procedure with Visualase. In 8 studies, epilepsy was the indication for Visualase (most common condition). Compared to NeuroBlate therapy, Visualase had no significant differences in frame, total complications, and length of stay. Waseem (2017) Key points: MRI-guided laser interstitial thermal therapy for epilepsy outcomes 38 patients with MRI-guided laser interstitial thermal therapy, followed six to 38 months. Fifty-three percent (18 of 38) had Engel class I outcome. Ten patients had repeat procedures, 12 post-procedural complications noted. Therapy associated with lower procedure time, hospitalization time, and analgesic requirement, vs. open surgery. References Professional society guidelines/other: Epilepsy Foundation. Learn. Important information about epilepsy and seizures. Epilepsy Foundation website. Accessed April 21, Harden CL, Hopp J, Ting TY, et al. Practice parameter update: management issues for women with epilepsy focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009; 73(2): Kwan P. For the International League Against Epilepsy (ILAE). Definition of drug resistant epilepsy. ILAE website. Accessed April 21, MD Edge. Modern epilepsy treatment modalities gain momentum. Conference coverage. Neurology Reviews. 2015;23(10):19. Accessed April 21, Morris GL, 3rd, Gloss D, Buchhalter J, et al. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;81(16):
7 National Institute for Health and Clinical Excellence (NICE). Epilepsies: diagnosis and management. (Clinical guideline; no. 137). January Last updated February NICE website. Accessed April 21, Smirniotopoulos JG, Wippold FJ II, Cornelius RS, et al. Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria seizures and epilepsy (online publication). Reston, VA: American College of Radiology (ACR); p. (52 references). Accessed April 21, U.S. Centers for Disease Control and Prevention (CDC). Epilepsy Fast Facts. Accessed April 21, U.S. Food and Drug Administration (FDA). 510(k) Premarket Notification Database. FDA website. Accessed April 21, U.S. Food and Drug Administration (FDA). MAUDE - Manufacturer and User Facility Device Experience. FDA website. Accessed April 21, Peer-reviewed references: Attiah MA, Paulo DL, Danish SF, Stein SC, Mani R. Anterior temporal lobectomy compared with laser thermal hippocampectomy for mesial temporal epilepsy: A threshold analysis study. Epilepsy Res. 2015; 115:1 7. Curry DJ, Gowda A, McNichols RJ, Wilfong AA. MR-guided stereotactic laser ablation of epileptogenic foci in children. Epilepsy Behavior. 2012;24(4): Engel J. Approaches to refractory epilepsy. Annals of the Indian Academy of Neurology. 2014;17(Suppl 1):S12 S17. Esquenazi Y, Kalamangalam GP, Slater JD, et al. Stereotactic laser ablation of epileptogenic periventricular nodular heterotopia. Epilepsy Research. 2014;108(3): Gonzalez-Martinez J, Vadera S, Mullin J, Enatsu R, Alexopoulos AV, Patwardhan R, et al. Robot-assisted stereotactic laser ablation in medically intractable epilepsy: operative technique. Neurosurgery. 2014;10 Suppl 2: Gross RE, Mahmoudi B, Riley JP. Less is more: novel less-invasive surgical techniques for mesial temporal lobe epilepsy that minimize cognitive impairment. Curr Opin Neurol. 2015;28(2):
8 Hawasli AH, Bagade S, Shimony JS, Miller-Thomas M, Leuthardt EC. Magnetic resonance imaging-guided focused laser interstitial thermal therapy for intracranial lesions: single-institution series. Neurosurgery. 2013;73(6): Hayes Inc., Hayes Medical Technology Report. Visualase (Medtronic) for MRI-guided laser ablation for epilepsy. Lansdale, Pa. Hayes Inc.; January 19, Hoppe C, Witt JA, Helmstaedter C, Gasser T, Vatter H, Elger CE. Laser interstitial thermotherapy (LiTT) in epilepsy surgery. Seizure. 2017;48: Kang JY, Sperling MR. Magnetic resonance imaging-guided laser interstitial thermal therapy for treatment of drug-resistant epilepsy. Neurotherapeutics. 2017;14(1): Kang JY, Wu C, Tracy J, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia. 2016;57(2): Karsy M, Guan J, Ducis K, Bollo RJ. Emerging surgical therapies in the treatment of pediatric epilepsy. Transl Pediatr. 2016;5(2): Lagman C, Chung LK, Pelargos PE, et al. Laser neurosurgery: a systematic analysis of magnetic resonance-guided laser interstitial thermal therapies. J Clin Neurosci. 2017;36: Lewis EC, Weil AG, Duchowny M, et al. MR-guided laser interstitial thermal therapy for pediatric drugresistant lesional epilepsy. Epilepsia. 2015;56(10): McCracken DJ, Willie JT, Fernald BA, et al. Magnetic resonance thermometry-guided stereotactic laser ablation of cavernous malformations in drug-resistant epilepsy: imaging and clinical results. Neurosurgery PMID: Muh CR. Current and emerging surgical therapies for severe pediatric epilepsies. Semin Pediatr Neurol. 2016;23(2): Patel P, Patel NV, Danish SF. Intracranial MR-guided laser-induced thermal therapy: single-center experience with the Visualase thermal therapy system. J Neurosurg. 2016:125(4): Quigg M, Harden C. Minimally invasive techniques for epilepsy surgery: stereotactic radiosurgery and other technologies. Journal of Neurosurgery. 2014;121 Suppl: Sun XR, Patel NV, Danish SF. Tissue ablation dynamics during magnetic resonance-guided, laser-induced thermal therapy. Neurosurgery. 2015;77(1):
9 Tovar-Spinoza Z, Carter D, Ferrone D, Eksioglu Y, Huckins S. The use of MRI-guided laser-induced thermal ablation for epilepsy. Childs Nervous System. 2013;29(11): Waseem H, Osborn KE, Schoenberg MR, et al. Laser ablation therapy: An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50. Epilepsy Behav. 2015;51: Waseem H, Vivas AC, Vale FL. MRI-guided laser interstitial thermal therapy for treatment of medically refractory non-lesional mesial temporal lobe epilepsy: outcomes, complications, and current limitations: a review. J Clin Neurosci. 2017;38:1 7. Wicks RT, Jermakowicz WJ, Jagid JR, et al. Laser interstitial thermal therapy for mesial temporal lobe epilepsy. Neurosurgery. 2016;79 Suppl 1:S83 S91. Wilfong AA, Curry DJ. Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis. Epilepsia. 2013;54 Suppl 9: Willie JT, Laxpati NG et al. Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery June;74(6): CMS National Coverage Determinations (NCDs): There are no NCDs as of the writing of this policy. Local Coverage Determinations (LCDs): There are no LCDs as of the writing of this policy. Commonly submitted codes Below are the most commonly submitted codes for the service(s)/item(s) subject to this policy. This is not an exhaustive list of codes. Providers are expected to consult the appropriate coding manuals and bill accordingly. CPT Code Description Comment Creation of a lesion by stereotaxic method, percutaneous, by neurolytic agent (e.g., alcohol, thermal, electrical, radiofrequency) Creation of lesion by stereotactic method, percutaneous, by neurolytic agent (e.g., alcohol, thermal, electrical, radiofrequency); trigeminal medullary tract ICD-10 Code Description Comment G Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status 9
10 ICD-10 Code Description Comment G G G G G G G G G G G Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status syndromes with simple partial seizures, not intractable, with status syndromes with simple partial seizures, not intractable, without status syndromes with simple partial seizures, intractable, with status syndromes with simple partial seizures, intractable, without status syndromes with complex partial seizures, not intractable, with status syndromes with complex partial seizures, not intractable, without status syndromes with complex partial seizures, intractable, with status syndromes with complex partial seizures, intractable, without status HCPCS Level II Code N/A Description Comment 10
Clinical Policy Title: Genicular nerve block
Clinical Policy Title: Genicular nerve block Clinical Policy Number: 14.01.10 Effective Date: October 1, 2017 Initial Review Date: September 21, 2017 Most Recent Review Date: October 19, 2017 Next Review
More informationClinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering)
Clinical Policy Title: Altered auditory feedback devices for speech dysfluency (stuttering) Clinical Policy Number: 17.02.02 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent
More informationClinical Policy Title: Strep testing
Clinical Policy Title: Strep testing Clinical Policy Number: 07.01.09 Effective Date: December 1, 2017 Initial Review Date: October 19, 2017 Most Recent Review Date: November 16, 2017 Next Review Date:
More informationClinical Policy Title: Cardiac rehabilitation
Clinical Policy Title: Cardiac rehabilitation Clinical Policy Number: 04.02.02 Effective Date: September 1, 2013 Initial Review Date: February 19, 2013 Most Recent Review Date: February 6, 2018 Next Review
More informationClinical Policy Title: Zoster (shingles) vaccine
Clinical Policy Title: Zoster (shingles) vaccine Clinical Policy Number: 18.02.10 Effective Date: June 1, 2018 Initial Review Date: April 10, 2018 Most Recent Review Date: May 1, 2018 Next Review Date:
More informationClinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden
Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:
More informationClinical Policy Title: Abdominal aortic aneurysm screening
Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: July 20, 2017 Next
More informationClinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening
Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent
More information21 ST CENTURY TECHNOLOGY IN PEDIATRIC NEUROLOGIC DISORDERS PEDIATRIC NEUROLOGIC DISORDERS YOUR LEARNING EXPERIENCE LEARNING OBJECTIVES
21 ST CENTURY TECHNOLOGY IN PEDIATRIC NEUROLOGIC DISORDERS Saturday, April 30, 2016 11:00 am David J. Siegler, M.D. Board Certified American Board of Psychiatry and Neurology National Board of Physicians
More informationClinical Policy Title: Abdominal aortic aneurysm screening
Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next
More informationClinical Policy Title: Abdominal aortic aneurysm screening
Clinical Policy Title: Abdominal aortic aneurysm screening Clinical Policy Number: 08.01.10 Effective Date: August 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: June 5, 2018 Next
More informationClinical Policy: Digital EEG Spike Analysis
Clinical Policy: Reference Number: CP.MP.105 Last Review Date: 01/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description
More informationClinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden
Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:
More informationAll patients with a diagnosis of treatment resistant (intractable) epilepsy.* Denominator Statement
MEASURE #7 Referral to Comprehensive Epilepsy Center Measure Description Percent of all patients with a diagnosis of treatment resistant (intractable) epilepsy who were referred for consultation to a comprehensive
More informationClinical Policy Title: Magnetoencephalography and magnetic source imaging
Clinical Policy Title: Magnetoencephalography and magnetic source imaging Clinical Policy Number: 09.01.07 Effective Date: January 1, 2015 Initial Review Date: July 16, 2014 Most Recent Review Date: July
More informationClinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab
Clinical Policy Title: Measurement of serum antibodies to infliximab and adalimumab Clinical Policy Number: 01.01.03 Effective Date: January 1, 2016 Initial Review Date: September 16, 2015 Most Recent
More informationSurgical Modalities for Epilepsy Treatment. C.J. Bui, MD, FAANS Ochsner Neuroscience Symposium 2016
Surgical Modalities for Epilepsy Treatment C.J. Bui, MD, FAANS Ochsner Neuroscience Symposium 2016 Conflict of Interest Nothing to disclose Surgical Modalities Diagnostic Subdural Grids Depth Electrodes
More informationSubject: Magnetoencephalography/Magnetic Source Imaging
01-95805-16 Original Effective Date: 09/01/01 Reviewed: 07/26/18 Revised: 08/15/18 Subject: Magnetoencephalography/Magnetic Source Imaging THIS MEDICAL COVERAGE GUIDELINE IS NOT AN AUTHORIZATION, CERTIFICATION,
More informationClinical Policy Title: Discography
Clinical Policy Title: Discography Clinical Policy Number: 03.01.01 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2017 Next Review Date: October
More informationEPILEPSY. New Ideas about an Old Disease. Gregory D. Cascino, MD
EPILEPSY New Ideas about an Old Disease Gregory D. Cascino, MD Disclosure Research-Educational Grants Neuro Pace, Inc. American Epilepsy Society American Academy of Neurology Neurology (Associate Editor)
More informationClinical Policy Title: Computerized gait analysis
Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: May 1, 2018 Next Review Date:
More informationClinical Policy Title: Ambulatory and video electroencephalography
Clinical Policy Title: Ambulatory and video Clinical Policy Number: 09.01.05 Effective Date: October 1, 2014 Initial Review Date: March 19, 2014 Most Recent Review Date: May 1, 2018 Next Review Date: May
More informationClinical Policy Title: Ketamine for treatment-resistant depression
Clinical Policy Title: Ketamine for treatment-resistant depression Clinical Policy Number: 00.02.13 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: January
More informationClinical Policy Title: Breast cancer index genetic testing
Clinical Policy Title: Breast cancer index genetic testing Clinical Policy Number: 02.01.22 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 19, 2016
More informationThe Surgical Treatment of Epilepsy
The Surgical Treatment of Epilepsy Jeffrey S. Schweitzer, MD, PhD Kaiser Los Angeles Medical Center Division of Restorative Neurosurgery Ancient craniotomy When Cao started complaining about splitting
More informationClinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)
Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most
More informationClinical Policy Title: Computerized gait analysis
Clinical Policy Title: Computerized gait analysis Clinical Policy Number: 15.01.01 Effective Date: October 1, 2014 Initial Review Date: May 21, 2014 Most Recent Review Date: June 22, 2017 Next Review Date:
More informationMagnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy for Treatment of Drug-Resistant Epilepsy
Neurotherapeutics (2017) 14:176 181 DOI 10.1007/s13311-016-0498-3 CURRENT PERSPECTIVES Magnetic Resonance Imaging-Guided Laser Interstitial Thermal Therapy for Treatment of Drug-Resistant Epilepsy Joon
More informationNOW WITH SYSTEM OVERVIEW MINIMALLY INVASIVE ROBOTIC LASER THERMOTHERAPY
NOW WITH SYSTEM OVERVIEW MINIMALLY INVASIVE ROBOTIC LASER THERMOTHERAPY Mini-Bolt Access Robotically Controlled Probe Driver MRI-Guided Laser Energy PRECISION AND CONFIDENCE DELIVERED THROUGH A MINIMALLY
More informationIntracranial Studies Of Human Epilepsy In A Surgical Setting
Intracranial Studies Of Human Epilepsy In A Surgical Setting Department of Neurology David Geffen School of Medicine at UCLA Presentation Goals Epilepsy and seizures Basics of the electroencephalogram
More informationClinical Policy Title: Ambulatory and video electroencephalogram (AEEG, VEEG)
Clinical Policy Title: Ambulatory and video electroencephalogram (AEEG, VEEG) Clinical Policy Number: 09.01.05 Effective Date: October 1, 2014 Initial Review Date: March 19, 2014 Most Recent Review Date:
More informationEPILEPSY 2018: UPDATE ON MODERN SURGICAL MANAGEMENT. Robert Kellogg, MD Advocate Children s Hospital Park Ridge, IL April 20, 2018
EPILEPSY 2018: UPDATE ON MODERN SURGICAL MANAGEMENT Robert Kellogg, MD Advocate Children s Hospital Park Ridge, IL April 20, 2018 No disclosures OBJECTIVES Brief history of epilepsy surgery Pre-operative
More informationClinical Policy Title: Room humidifiers
Clinical Policy Title: Room humidifiers Clinical Policy Number: 17.02.05 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review Date:
More informationClinical Policy Title: Vacuum assisted closure in surgical wounds
Clinical Policy Title: Vacuum assisted closure in surgical wounds Clinical Policy Number: 17.03.00 Effective Date: September 1, 2015 Initial Review Date: June 16, 2013 Most Recent Review Date: August 17,
More informationClinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT)
Clinical Policy Title: Immediate post-concussion assessment and cognitive testing (ImPACT) Clinical Policy Number: 09.01.02 Effective Date: September 1, 2013 Initial Review Date: February 18, 2013 Most
More informationSYSTEM OVERVIEW MINIMALLY INVASIVE ROBOTIC LASER THERMOTHERAPY
SYSTEM OVERVIEW MINIMALLY INVASIVE ROBOTIC LASER THERMOTHERAPY Software NeuroBlate Fusion Software is the exclusive software intelligence behind the NeuroBlate System. NeuroBlate Fusion allows neurosurgeons
More informationDepartment of Neurosurgery, Children s National Medical Center, Washington, DC
NEUROSURGICAL FOCUS Neurosurg Focus 45 (3):E8, 2018 Early outcomes of stereoelectroencephalography followed by MR-guided laser interstitial thermal therapy: a paradigm for minimally invasive epilepsy surgery
More informationClinical Policy: Functional MRI Reference Number: CP.MP.43
Clinical Policy: Reference Number: CP.MP.43 Effective Date: 09/09 Last Review Date: 10/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationClinical Policy Title: Spinal cord stimulators for chronic pain
Clinical Policy Title: Spinal cord stimulators for chronic pain Clinical Policy Number: 03.03.01 Effective Date: October 1, 2014 Initial Review Date: March 19, 2014 Most Recent Review Date: April 19, 2017
More informationSurgery for Medically Refractory Focal Epilepsy
Surgery for Medically Refractory Focal Epilepsy Seth F Oliveria, MD PhD The Oregon Clinic Neurosurgery Director of Functional Neurosurgery: Providence Brain and Spine Institute Portland, OR Providence
More informationClinical Policy Title: Cryoneurolysis
Clinical Policy Title: Cryoneurolysis Clinical Policy Number: 09.02.08 Effective Date: May 1, 2017 Initial Review Date: April 19, 2017 Most Recent Review Date: April 19, 2017 Next Review Date: April 2018
More informationClinical Policy Title: Tactile breast imaging
Clinical Policy Title: Tactile breast imaging Clinical Policy Number: 05.01.07 Effective Date: February 1, 2018 Initial Review Date: November 16, 2017 Most Recent Review Date: January 11, 2018 Next Review
More informationClinical Policy: Vagus Nerve Stimulation Reference Number: PA.CP.MP.12
Clinical Policy: Reference Number: PA.CP.MP.12 Effective Date: 01/18 Last Review Date: 09/18 Coding Implications Revision Log Description Vagus nerve stimulation (VNS) has been used in the treatment of
More informationClinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155
Clinical Policy: EEG in the Evaluation of Headache Reference Number: CP.MP.155 Effective Date: 12/17 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy
More informationThe Changing Surgical Landscape in Kids
The Changing Surgical Landscape in Kids December 7, 2013 Howard L. Weiner, MD NYU Langone Medical Center American Epilepsy Society Annual Meeting Disclosure none American Epilepsy Society 2013 Annual Meeting
More informationClinical Policy Title: Outpatient diabetes self-management training (DSMT)
Clinical Policy Title: Outpatient diabetes self-management training (DSMT) Clinical Policy Number: 06.02.02 Effective Date: July 1, 2013 Initial Review Date: April 23, 2013 Most Recent Review Date: March
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: vagus_nerve_stimulation 6/1998 5/2017 5/2018 5/2017 Description of Procedure or Service Stimulation of the
More informationClinical Policy: Ambulatory Electroencephalography Reference Number: CP.MP.96
Clinical Policy: Ambulatory Electroencephalography Reference Number: CP.MP.96 Effective Date: 09/15 Last Review Date: 09/17 See Important Reminder at the end of this policy for important regulatory and
More informationMultimodal Imaging in Extratemporal Epilepsy Surgery
Open Access Case Report DOI: 10.7759/cureus.2338 Multimodal Imaging in Extratemporal Epilepsy Surgery Christian Vollmar 1, Aurelia Peraud 2, Soheyl Noachtar 1 1. Epilepsy Center, Dept. of Neurology, University
More informationClinical Policy Title: Investigational (experimental) health services
Clinical Policy Title: Investigational (experimental) health services Clinical Policy Number: 18.04.03 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: September
More informationThe Role of a Vascular Surgeon in the Treatment of Drug Resistant Epilepsy
The Role of a Vascular Surgeon in the Treatment of Drug Resistant Epilepsy Alberto J Lopez MD FACS Assistant Professor of Surgery University of Miami, Jackson Memorial Hospital and VA Medical Center Miami
More informationClinical Policy Title: Ear tubes (tympanostomy)
Clinical Policy Title: Ear tubes (tympanostomy) Clinical Policy Number: 11.03.05 Effective Date: January 1, 2015 Initial Review Date: September 17, 2014 Most Recent Review Date: September 21, 2017 Next
More informationClinical Policy Title: Subtalar arthroereisis (implant)
Clinical Policy Title: Subtalar arthroereisis (implant) Clinical Policy Number: 14.03.05 Effective Date: April 1, 2017 Initial Review Date: August 17, 2016 Most Recent Review Date: September 21, 2017 Next
More informationResearch and Advances in Epilepsy. Preeti Puntambekar, MD, PHD Epileptologist Northeast regional epilepsy group
Research and Advances in Epilepsy Preeti Puntambekar, MD, PHD Epileptologist Northeast regional epilepsy group Epilepsy History Hippocrateson the sacred disease Galen Avicenna Middle ages Renaissance Paracelcus
More informationClinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening
Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent
More informationClinical Policy Title: Home phototherapy for hyperbilirubinemia
Clinical Policy Title: Home phototherapy for hyperbilirubinemia Clinical Policy Number: 11.02.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17,
More informationAccepted Manuscript. Editorial. Responsive neurostimulation for epilepsy: more than stimulation. Jayant N. Acharya
Accepted Manuscript Editorial Responsive neurostimulation for epilepsy: more than stimulation Jayant N. Acharya PII: S2467-981X(18)30022-2 DOI: https://doi.org/10.1016/j.cnp.2018.06.002 Reference: CNP
More informationA Minimally Invasive Option for Patients Considering Brain Surgery
PATIENT S GUIDE A Minimally Invasive Option for Patients Considering Brain Surgery MINIMALLY INVASIVE ROBOTIC LASER THERMOTHERAPY Robotically Controlled Probe Driver Precise nature of the NeuroBlate System
More informationApproximately 70% of childhood SURGICAL TREATMENTS FOR PEDIATRIC EPILEPSY PROCEEDINGS. Ronald P. Lesser, MD KEY POINTS
ASIM May p153-158 5/14/01 9:19 AM Page 153 SURGICAL TREATMENTS FOR PEDIATRIC EPILEPSY Ronald P. Lesser, MD KEY POINTS Most children with epilepsy refractory to drugs can improve with surgery Temporal lobe
More informationClinical Policy Title: Bone growth stimulators for non-healing fractures
Clinical Policy Title: Bone growth stimulators for non-healing fractures Clinical Policy Number: 14.02.03 Effective Date: January 1, 2015 Initial Review Date: July 16, 2014 Most Recent Review Date: March
More informationClinical Policy Title: Genetic testing for Alzheimer s disease
Clinical Policy Title: Genetic testing for Alzheimer s disease Clinical Policy Number: 02.01.20 Effective Date: July 1, 2016 Initial Review Date: May 18, 2016 Most Recent Review Date: April 10, 2018 Next
More information9/30/2016. Advances in Epilepsy Surgery. Epidemiology. Epidemiology
Advances in Epilepsy Surgery George Jallo, M.D. Director, Institute for Brain Protection Sciences Johns Hopkins All Children s Hospital St Petersburg, Florida Epidemiology WHO lists it as the second most
More informationDr H. Gharebaghian MD Neurologist Department of Neurology Kermanshah Faculty of Medicine
Dr H. Gharebaghian MD Neurologist Department of Neurology Kermanshah Faculty of Medicine Definitions Seizures are transient events that include symptoms and/or signs of abnormal excessive hypersynchronous
More informationClinical Policy Title: Bloodless heart transplant
Clinical Policy Title: Bloodless heart transplant Clinical Policy Number: 05.03.05 Effective Date: July 1, 2017 Initial Review Date: June 22, 2017 Most Recent Review Date: July 20, 2017 Next Review Date:
More informationLaser ablation under real-time magnetic. Robot-Assisted Stereotactic Laser Ablation in Medically Intractable Epilepsy: Operative Technique
Operative Technique Robot-Assisted Stereotactic Laser Ablation in Medically Intractable Epilepsy: Operative Technique Jorge Gonzalez-Martinez, MD, PhD* Sumeet Vadera, MD* Jeffrey Mullin, MD, MBA* Rei Enatsu,
More informationfocus Neurosurg Focus 41 (4):E10, 2016
neurosurgical focus Neurosurg Focus 41 (4):E10, 2016 Stereotactic laser ablation for hypothalamic and deep intraventricular lesions Robert T. Buckley, MD, 1 Anthony C. Wang, MD, 1 John W. Miller, MD, PhD,
More informationEpilepsy & Behavior Case Reports
Epilepsy & Behavior Case Reports 1 (2013) 45 49 Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr Case Report Partial disconnection
More informationSee Policy CPT/HCPCS CODE section below for any prior authorization requirements
Effective Date: 1/1/2019 Section: SUR Policy No: 395 1/1/19 Medical Policy Committee Approved Date: 8/17; 2/18; 12/18 Medical Officer Date APPLIES TO: Medicare Only See Policy CPT/HCPCS CODE section below
More informationClinical Policy Title: Tumor treatment fields for glioblastoma
Clinical Policy Title: Tumor treatment fields for glioblastoma Clinical Policy Number: 05.02.05 Effective Date: July 1, 2015 Initial Review Date: March 18, 2015 Most Recent Review Date: April 19, 2017
More informationRecommendations. for Care of Adults with Epilepsy. Seeking the best treatment from the right doctor at the right time!
Recommendations for Care of Adults with Epilepsy Seeking the best treatment from the right doctor at the right time! Contents This booklet is to help adults and their caregivers know when it is appropriate
More informationClinical Policy Title: Applied behavior analysis (ABA)
Clinical Policy Title: Applied behavior analysis (ABA) Clinical Policy Number: 11.04.03 Effective Date: October 1, 2015 Initial Review Date: May 15, 2015 Most Recent Review Date: June 15, 2016 Next Review
More informationMedStar Health considers Cough Assist Devices medically necessary for the following indications:
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.047.MH Cough Assist Devices This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP MedStar CareFirst
More informationClinical Policy Title: Epidermal nerve fiber density testing
Clinical Policy Title: Epidermal nerve fiber density testing Clinical Policy Number: CCP.1263 Effective Date: January 1, 2017 Initial Review Date: October 19, 2016 Most Recent Review Date: October 2, 2018
More informationCurrent Literature In Clinical Science. Temporal Lobectomies in Children: More Than Just for Seizure Control?
Current Literature In Clinical Science Temporal Lobectomies in Children: More Than Just for Seizure Control? Long-Term Intellectual Outcome After Temporal Lobe Surgery in Childhood. Skirrow C, Cross JH,
More informationNeuromodulation in Epilepsy. Gregory C. Mathews, M.D., Ph.D.
Neuromodulation in Epilepsy Gregory C. Mathews, M.D., Ph.D. Disclosure There are no disclosures to share with regards to this presentation. Epilepsy Basics What is epilepsy? Partial versus generalized
More informationEpilepsy Surgery, Imaging, and Intraoperative Neuromonitoring: Surgical Perspective
Epilepsy Surgery, Imaging, and Intraoperative Neuromonitoring: Surgical Perspective AC Duhaime, M.D. Director, Pediatric Neurosurgery, Massachusetts General Hospital Professor, Neurosurgery, Harvard Medical
More informationSubject: Brain CT. Original Effective Date: 11/7/2017. Policy Number: MCR: 600. Revision Date(s): Review Date:
Subject: Brain CT Policy Number: MCR: 600 Revision Date(s): MHW Original Effective Date: 11/7/2017 Review Date: DISCLAIMER This Molina Clinical Review (MCR) is intended to facilitate the Utilization Management
More informationClinical Policy Title: Intralesional steroid injection for acne
Clinical Policy Title: Intralesional steroid injection for acne Clinical Policy Number: 16.02.07 Effective Date: June 1, 2017 Initial Review Date: April 19, 2017 Most Recent Review Date: May 19, 2017 Next
More informationClinical Policy Title: Radiofrequency ablation treatment for spine pain
Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Number: 03.02.02 Effective Date: June 1, 2013 Initial Review Date: March 21, 2013 Most Recent Review Date: March
More informationClinical Policy Title: Radiofrequency ablation treatment for spine pain
Clinical Policy Title: Radiofrequency ablation treatment for spine pain Clinical Policy Number: 03.02.02 Effective Date: June 1, 2013 Initial Review Date: March 21, 2013 Most Recent Review Date: February
More informationMedStar Health considers Continuous Home Pulse Oximetry medically necessary for the following indications:
MedStar Health, Inc. POLICY AND PROCEDURE MANUAL MP.006.MH Continuous Home Pulse Oximetry This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP MedStar
More informationClinical Policy: Essure Removal Reference Number: CP.MP.131
Clinical Policy: Reference Number: CP.MP.131 Effective Date: 11/16 Last Review Date: 11/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More information5/22/2009. Pediatric Neurosurgery Pediatric Neurology Neuroradiology Neurophysiology Neuropathology Neuropsychology
Current Surgical Treatment Strategies for the Management of Pediatric Epilepsy University of California, San Francisco Department of Neurological Surgery San Francisco, California Kurtis Ian Auguste, M.D.
More informationClinical Policy Title: Bronchial thermoplasty for severe asthma
Clinical Policy Title: Bronchial thermoplasty for severe asthma Clinical Policy Number: 07.03.01 Effective Date: March 1, 2013 Initial Review Date: October 16, 2013 Most Recent Review Date: October 19,
More informationClinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy
Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy Reference: NHS England xxx/x/x 1 Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy First published:
More informationVagus Nerve Stimulation (VNS)
Vagus Nerve Stimulation (VNS) Date of Origin: 12/2008 Last Review Date: 06/27/2018 Effective Date: 07/01/2018 Dates Reviewed: 07/2010, 07/2011, 07/2012, 05/2013, 07/2014, 01/2016, 01/2017, 06/2018 Developed
More informationCortical Stimulation for Epilepsy (NeuroPace )
(NeuroPace ) Last Review Date: October 13, 2017 Number: MG.MM.SU.69 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit
More informationClinical Policy Title: Platelet rich plasma
Clinical Policy Title: Platelet rich plasma Clinical Policy Number: 05.02.10 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2016 Next Review
More informationResponsive Neurostimulation for the Treatment of Refractory Partial Epilepsy. Summary
Page: 1 of 12 Last Review Status/Date: March 2015 Refractory Partial Epilepsy Summary Responsive neurostimulation (RNS) for the treatment of epilepsy involves the use of 1 or more implantable electric
More informationAge at onset in patients with medically refractory. temporal lobe epilepsy and mesial temporal sclerosis: impact on clinical manifestations and
Thomas Jefferson University Jefferson Digital Commons Department of Neurology Faculty Papers Department of Neurology 8-1-2015 Age at onset in patients with medically refractory temporal lobe epilepsy and
More informationClinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy (all ages) NHS England Reference: P
Clinical Commissioning Policy: Deep Brain Stimulation for Refractory Epilepsy (all ages) NHS England Reference: 1736P NHS England INFORMATION READER BOX Directorate Medical Operations and Information
More information1. POLICY: Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Essential Tremor
Retired Date: Page 1 of 10 1. POLICY: Magnetic Resonance Image (MRgFUS) for Essential Tremor 2. RESPONSIBLE PARTIES: Medical Management Administration, Utilization Management, Integrated Care Management,
More informationClinical Policy: Robotic Surgery Reference Number: CP.MP. 207
Clinical Policy: Robotic Surgery Reference Number: CP.MP. 207 Effective Date: 03/05 Last Review Date: 10/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important
More informationClinical Policy Title: Platelet rich plasma
Clinical Policy Title: Platelet rich plasma Clinical Policy Number: 05.02.10 Effective Date: February 1, 2017 Initial Review Date: November 16, 2016 Most Recent Review Date: November 16, 2017 Next Review
More informationClinical Policy Title: Genetic testing for Alzheimer s disease
Clinical Policy Title: Genetic testing for Alzheimer s disease Clinical Policy Number: 02.01.20 Effective Date: July 1, 2016 Initial Review Date: May 18, 2016 Most Recent Review Date: May 19, 2017 Next
More information